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ABSTRACT
Based on its relation to the liver sinusoid, increased pressure of portal vein can occur at three levels:
presinusoid, sinusoid ,and postsinusoid. Obstruction of the presinusoid veins can be caused by extra-he-
patic condition such as venous thrombosis.
We reported a case of portal hypertension with esophageal varices bleeding was a result of obstruction
due to thrombosis of the splenic vein and portal vein under hypercoagulant conditions due to thrombocyto-
sis.  The management of esophageal varices was sclerotherapy while for overcome the thrombosis the patient
was given hydroxy urea.
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INTRODUCTION
Portal hypertension is defined as increased portal vein
pressure of over 30 cmH20, often caused by increased
pressure on the portal blood flow. Based on its relation
to the liver sinusoid, increased pressure can occur at
three levels, presinusoid, sinusoid, and postsinusoid. Ob-
struction of the presinusoid veins can anatomically be
caused by extra-hepatic conditions (such as venous
thrombosis and increased splenic blood flow), or at the
proximal of the liver sinusoid, preventing the liver paren-
chyme from exposure towards increased venous pres-
sure (such as schistosomiasis). Postsinusoidal obstruc-
tion may be caused by the Budd-Chiari syndrome and
veno-occlusive diseases. Cirrhosis causes portal hyper-
tension at the sinusoid level.1,2,3
Liver cirrhosis is the most common disease that
causes portal hypertension. Portal vein obstruction is the
second most common cause, which can be idiopathic or
may be related to liver cirrhosis, infection, abdominal
trauma, congenital malformations of the portal vein, post-
surgical conditions, autoimmune diseases, changes in the
walls of the portal vein due to inflammation, malignancy,
pancreatic disorders, etc.1,3,4,5,6 Pancreatic disorders may
take the form of pancreatitis, carcinoma, and cysts.3
Pancreatic cysts may take the form of pseudocysts, se-
rous cystadenoma, mucinous cyst neoplasm, and muci-
nous cystadenocarcinoma.7 Malignant disorders may
cause portal vein thrombosis through direct invasion of
the portal vein, external compression of the portal vein,
or periportal fibrosis due to surgery or radiotherapy.
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Chronic pancreatitis is often accompanied by splenic vein
thrombosis.4
Venous obstruction may also be caused by thrombo-
sis under hypercoagulant conditions, such as venous
policytemia, thrombocytosis, or deficiency of protein C,
protein S, or antithrombin III. Thrombocytosis can be
primary (in myeloproliferative conditions) or secondary
(such as in iron deficiency anemia, chronic inflamma-
tory diseases, post-surgical conditions, malignancy, and
so forth). 1,3,6,8
Clinical manifestations of portal hypertension include
abdominal discomfort, gastric and esophageal varices
bleeding, splenomegaly, hypersplenism, ascites, and acute
and chronic encephalopathy if severe. Under non-cir-
rhotic conditions, patients with splenomegaly with va-
riceal bleeding should be suspected of splenic vein or
portal vein thrombosis. 1,3,8,9 Normal liver biopsy may
demonstrate mild changes in portal hypertension due to
extra-hepatic portal vein obstruction. 5, 10, 11 Radiologic
imaging such as ultra-sonography, Computerized Tomog-
raphy Scan (CT-scan), Magnetic Resonance Imaging
(MRI), angiography, and splenoportography may assist
the investigation of the cause of portal vein obstruction.
3, 4, 8
Treatment is usually aimed at alleviation of the com-
plications of portal hypertension. Bleeding must be con-
trolled. Avoid administration of aspirin. Somatostatin and
sclerotherapy may be used.3,12 If bleeding has been
managed, investigate the cause of portal hypertension.
If esophageal varices bleeding is caused by portal vein
thrombosis due to thrombocytosis, reduction of platelet
count by means of cytotoxic drugs is more advisable
than surgery.4 Beta-adrenergic blockers such as
propanolol or nadolol, in addition to being capable of re-
ducing portal pressure through a vasodilatation effect on
the splancnic arterial flow and the portal vein system, in
addition to by reducing cardiac output. Splenectomy is
indicated in excessively large spleens, hypersplenism, and
obstruction of the splenic vein. 1, 2, 3
CASE REPORT
Mr. S, 52 years old, middle class, was hospitalized on
the fourth floor of the B in-patient ward of Cipto
Mangunkusumo Hospital from the 28th of May, 1999,
due to complaints of pain on the upper left abdomen since
1 year prior to hospital admission. The pain was sudden
in nature, recurrent, did not spread and was so severe
that the patient was unable to walk. There was no nau-
sea and vomiting, and there was no fever. The patient
defecated as usual. The patient was hospitalized at the
Red Cross Hospital, Bogor, for one week and received
3 kinds of medications. The patient was released when
he was relieved of his symptoms.
Ten months following admission there was swelling
of the upper left abdomen, sometimes accompanied by
intense pain, which recurred and did not spread. The
patient was readmitted to the Red Cross Hospital.
Three months following the second admission, the
patient vomited and defecated black stool. The patient
was admitted for the third time to the Red Cross Hospi-
tal. He received 10 packages of red transfusion and 4
packs of yellowish transfusion. The patient was advised
to be treated at Cipto Mangunkusumo Hospital. The
patient denied any history of alcoholism, herb drinking,
and smoking. The patient often suffered from general-
ized weakness.
During physical examination, we found the patient to
be moderately ill, fully conscious, with a blood pressure
of 110/70 mmHg, a pulse rate of 90 times/minute, a tem-
perature of 37°C, and a respiratory rate of 20 times/
minute. His conjunctiva were not pale. His sclera showed
no signs of jaundice. His jugular venous pressure was 5-
2 cm H2O. His lungs were sonor, vesicular, without and
rales/crackles or wheezing. First and second heart
sounds were pure, without any gallop or murmur. His
abdomen was not distended. His liver was not palpable.
His spleen was palpable at Schuffner III, pliant, smooth,
with rounded edges and without tenderness. No mass
was palpable. There was no lymph node enlargement.
There was no palmar erythema and spider nevi.
Laboratory findings were as follows: Hemoglobin
level 11,2 g/dL, Hematocryte 38 vol %, leukocyte count
27.800/mL, platelet count 1.499.000/mL, LED 10 mm/
hour. Urine evaluation findings were as follows: specific
gravity 1020, pH 6, leukocyte count 4-5/LPB. No eryth-
rocyte was found in the urine. The patient’s albumin level
was 4,7 g/dL, his globulin level 3,3 g/dL, and total biliru-
bin 0,5 mg/dL.
Chest x-ray demonstrated a cardiothoracic ratio
(CTR) of less than 50%. There was no infiltrates in the
lungs.
During admission, the following problems were es-
tablished: 1. Splenomegaly, 2. Anemia, 3. Thrombocyto-
sis and leukocytosis.
During further evaluation, abdominal ultrasound dem-
onstrated chronic hepatitis with multiple pancreatic cysts
and splenomegaly. Abdominal CT-scan without contrast
demonstrated mass on the pancreatic head and splenom-
egaly. Abdominal CT-scan using contrast demonstrated
splenomegaly, chronic liver disease, and suspected tu-
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mor of the pancreatic head with a differential diagnosis
of pancreatitis and carcinoma of the pancreatic head.
Blood amylase level was 241 S. Somogryi (Normal: 90-
150) and his blood lipase level was 250 U/I (Normal:
<190). His CA was 19-9: 31 U/mL (Normal: <35). Dop-
pler ultrasound demonstrated increased portal vein pres-
sure, with a suspicion towards portal vein thrombosis.
Liver biopsy demonstrated an image that was in line with
chronic hepatitis, with a differential diagnosis of liver
without significant disorder. The cause of portal hyper-
tension seem to be infra-hepatic. HBsAg and anti-HCV
IgM  were negative. His SGOT was 38 U/I, SGPT 23
U/I, cholin-esterase 3,4 kU/I, ureum 40 mg/dL, and crea-
tinine 0,44 mg/dL. Direct splenography demonstrated
enlargement of the hillus, and enlargement and winding
of the splenic vein1/3 proximal of the spleen,as well as
enlargement of the left gastric vein (coronary vein). There
was no enlargement of the portal vein. The findings indi-
cated varices of the coronary vein, the 1/3 proximal
splenic vein, with obstruction of the portal vein. The pa-
tient was then consulted with the Portal Team and was
scheduled for splenectomy. On the 13 day of treatment,
the patient vomited and defecated blood, suspected to
be due to rupture of esophageal varices. Hemostasis
evaluation demonstrated compensated DIC, with a
Protombin Time of 14,6 (control: 11-14), aPTT of 32,5
(control: 30-40) and positive D-dimer. Endoscopy dem-
onstrated grade II-III esophageal varices of the 1/3
middle to 1/3 distal esophagus, cardiac varices, portal
hypertension gastropathy, and mild anthral gastritis. The
patient then underwent endoscopic sclerotherapy and
underwent seven sessions of sclerotherapy.
Further blood laboratory evaluation demonstrated 13%
reticulocyte, with   microcytic hypochrom morphology.
Iron evaluation was 20, UIBC: 345. Benzidine test turned
out negative. Bone marrow hemosiderin was reduced.
The patient was suspected for iron deficiency anemia.
During bleeding, the patient’s hemoglobin level was 8,4.
The patient received 250 cc of packed red cell (PRC)
transfusion followed by 2x1 tablet of sulfasferosus. The
following month, there was an increase of MCV to 70 m
and MCH of 23 pg.
Bone marrow puncture demonstrated a hypocellular
condition. Bone marrow biopsy demonstrated a
hypercellular bone marrow tissue. Platelet physiology
demonstrated platelet hyperaggregation. The patient was
treated with 2x1 tablet of hydoxyurea, 1 x 300 mg of
Allopurinol, and 3 x 500 mg  of Bicarbonas natricus. On
the eleventh day of treatment, the patient’s platelet and
leukocyte count dropped, and the dosage of hydroxyurea
was adjusted.
DISCUSSION
Absence of cirrhosis during liver biopsy demonstrated
that in this case, portal hypertension is a result of ob-
struction of the splenic vein and the portal vein, due to
thrombosis of the splenic vein and portal vein under
hypercoagulant conditions due to thrombocytosis. There
is also the possibility of obstruction due to fibrosis of the
pancreas, infiltrating the walls of the splenic vein, caus-
ing thrombus or cystic tumor of the pancreatic head,
obstructing the portal vein and the splenic vein. 1,3, 4 In
this case, further exploration of the cause of obstruction
during surgery is required.
In this patient, the problem of anemia was established
based on history of generalized weakness, as well as
bloody vomiting and defecation. Physical examination
demonstrated a pale conjunctiva and a hemoglobin level
of 11,2 g/dL. Anemia was though to be due to bleeding
and iron deficiency. Iron deficiency anemia may also be
the cause of secondary thrombocytosis. However, when
treatment with hydroxyurea was terminated, there was
an increase in hematocryte with normocytic
normochrome erythrocyte morphology and a maintained
increase in platelet count. Thus, primary thrombocytosis
still cannot be crossed out.13, 14, 15, 16
The patient underwent sclerotherapy for esophageal
varices, and no recurrent bleeding was found following
sclerotherapy. This is in line with literature that stated
that a drop in incidence and risk of recurrent bleeding is
found in patients with extra-hepatic portal vein obstruc-
tion (with maintained liver function) undergoing sclero-
therapy.17, 18, 19
Shunt construction, possibly without splenectomy, is
the definite ideal treatment in patients with extra-hepatic
portal hypertension with esophageal varices to avoid
unwanted effects such as thrombocytosis, abdominal
venous infarction, sensitivity towards infection, and the
possibility of more significant bleeding due to loss of
collaterals. Nevertheless, emergency conditions or other
conditions with large varices, high risk, and difficulty in
treatment with sclerosis alone, or absence of a suitable
blood vessel for shunting, as in this case, splenectomy is
a choice and is not always followed by an adversary
outcome. 3, 20
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